Cargando…

Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study

INTRODUCTION: Coagulation and fibrinolysis remain sparsely addressed with regards to acute respiratory distress syndrome (ARDS). We hypothesized that ARDS development might be associated with changes in plasma coagulation and fibrinolysis. Our aim was to investigate the relationships between ARDS di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozolina, Agnese, Sarkele, Marina, Sabelnikovs, Olegs, Skesters, Andrejs, Jaunalksne, Inta, Serova, Jelena, Ievins, Talis, Bjertnaes, Lars J., Vanags, Indulis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125303/
https://www.ncbi.nlm.nih.gov/pubmed/27965960
http://dx.doi.org/10.3389/fmed.2016.00064
_version_ 1782469957881167872
author Ozolina, Agnese
Sarkele, Marina
Sabelnikovs, Olegs
Skesters, Andrejs
Jaunalksne, Inta
Serova, Jelena
Ievins, Talis
Bjertnaes, Lars J.
Vanags, Indulis
author_facet Ozolina, Agnese
Sarkele, Marina
Sabelnikovs, Olegs
Skesters, Andrejs
Jaunalksne, Inta
Serova, Jelena
Ievins, Talis
Bjertnaes, Lars J.
Vanags, Indulis
author_sort Ozolina, Agnese
collection PubMed
description INTRODUCTION: Coagulation and fibrinolysis remain sparsely addressed with regards to acute respiratory distress syndrome (ARDS). We hypothesized that ARDS development might be associated with changes in plasma coagulation and fibrinolysis. Our aim was to investigate the relationships between ARDS diagnosis and plasma concentrations of tissue factor (TF), tissue plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1) in mechanically ventilated patients at increased risk of developing ARDS. MATERIALS AND METHODS: We performed an ethically approved prospective observational pilot study. Inclusion criteria were patients with PaO(2)/FiO(2) < 300 mmHg admitted to the intensive care unit (ICU) for mechanical ventilation for 24 h, or more, because of one or more disease conditions associated with increased risk of developing ARDS. Exclusion criteria were age below 18 years; cardiac disease. We sampled plasma prospectively and compared patients who developed ARDS with those who did not using descriptive statistics and chi-square analysis of baseline demographical and clinical data. We also analyzed plasma concentrations of TF, t-PA, and PAI-1 at inclusion (T(0)) and on third (T(3)) and seventh day (T(7)) of the ICU stay with non-parametric statistics inclusive their sensitivity and specificity associated with the development of ARDS using receiver operating characteristic curve analysis. Statistical significance: p < 0.05. RESULTS: Of 24 patients at risk, 6 developed mild ARDS and 4 of each moderate or severe ARDS, respectively, 3 ± 2 (mean ± SD) days after inclusion. Median plasma concentrations of TF and PAI-1 were significantly higher at T(7) in patients with ARDS, as compared to non-ARDS. Simultaneously, we found moderate correlations between plasma concentrations of TF and PAI-1, TF and PaO(2)/FiO(2), and positive end-expiratory pressure and TF. TF plasma concentration was associated with ARDS with 71% sensitivity and 100% specificity, a cut off level of 145 pg/ml and AUC 0.78, p = 0.02. PAI-1 displayed 64% sensitivity and 100% specificity with a cut off concentration of 117.5 pg/ml and AUC 0.77, p = 0.02. t-PA did not change significantly during the observation time. CONCLUSION: This pilot study showed that increased plasma concentrations of TF and PAI-1 might support ARDS diagnoses in mechanically ventilated patients after 7 days in ICU.
format Online
Article
Text
id pubmed-5125303
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-51253032016-12-13 Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study Ozolina, Agnese Sarkele, Marina Sabelnikovs, Olegs Skesters, Andrejs Jaunalksne, Inta Serova, Jelena Ievins, Talis Bjertnaes, Lars J. Vanags, Indulis Front Med (Lausanne) Medicine INTRODUCTION: Coagulation and fibrinolysis remain sparsely addressed with regards to acute respiratory distress syndrome (ARDS). We hypothesized that ARDS development might be associated with changes in plasma coagulation and fibrinolysis. Our aim was to investigate the relationships between ARDS diagnosis and plasma concentrations of tissue factor (TF), tissue plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1) in mechanically ventilated patients at increased risk of developing ARDS. MATERIALS AND METHODS: We performed an ethically approved prospective observational pilot study. Inclusion criteria were patients with PaO(2)/FiO(2) < 300 mmHg admitted to the intensive care unit (ICU) for mechanical ventilation for 24 h, or more, because of one or more disease conditions associated with increased risk of developing ARDS. Exclusion criteria were age below 18 years; cardiac disease. We sampled plasma prospectively and compared patients who developed ARDS with those who did not using descriptive statistics and chi-square analysis of baseline demographical and clinical data. We also analyzed plasma concentrations of TF, t-PA, and PAI-1 at inclusion (T(0)) and on third (T(3)) and seventh day (T(7)) of the ICU stay with non-parametric statistics inclusive their sensitivity and specificity associated with the development of ARDS using receiver operating characteristic curve analysis. Statistical significance: p < 0.05. RESULTS: Of 24 patients at risk, 6 developed mild ARDS and 4 of each moderate or severe ARDS, respectively, 3 ± 2 (mean ± SD) days after inclusion. Median plasma concentrations of TF and PAI-1 were significantly higher at T(7) in patients with ARDS, as compared to non-ARDS. Simultaneously, we found moderate correlations between plasma concentrations of TF and PAI-1, TF and PaO(2)/FiO(2), and positive end-expiratory pressure and TF. TF plasma concentration was associated with ARDS with 71% sensitivity and 100% specificity, a cut off level of 145 pg/ml and AUC 0.78, p = 0.02. PAI-1 displayed 64% sensitivity and 100% specificity with a cut off concentration of 117.5 pg/ml and AUC 0.77, p = 0.02. t-PA did not change significantly during the observation time. CONCLUSION: This pilot study showed that increased plasma concentrations of TF and PAI-1 might support ARDS diagnoses in mechanically ventilated patients after 7 days in ICU. Frontiers Media S.A. 2016-11-28 /pmc/articles/PMC5125303/ /pubmed/27965960 http://dx.doi.org/10.3389/fmed.2016.00064 Text en Copyright © 2016 Ozolina, Sarkele, Sabelnikovs, Skesters, Jaunalksne, Serova, Ievins, Bjertnaes and Vanags. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Ozolina, Agnese
Sarkele, Marina
Sabelnikovs, Olegs
Skesters, Andrejs
Jaunalksne, Inta
Serova, Jelena
Ievins, Talis
Bjertnaes, Lars J.
Vanags, Indulis
Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title_full Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title_fullStr Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title_full_unstemmed Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title_short Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: A Prospective Pilot Study
title_sort activation of coagulation and fibrinolysis in acute respiratory distress syndrome: a prospective pilot study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125303/
https://www.ncbi.nlm.nih.gov/pubmed/27965960
http://dx.doi.org/10.3389/fmed.2016.00064
work_keys_str_mv AT ozolinaagnese activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT sarkelemarina activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT sabelnikovsolegs activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT skestersandrejs activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT jaunalksneinta activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT serovajelena activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT ievinstalis activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT bjertnaeslarsj activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy
AT vanagsindulis activationofcoagulationandfibrinolysisinacuterespiratorydistresssyndromeaprospectivepilotstudy